Buchang Investment (7878J)
05 Luglio 2011 - 12:09PM
UK Regulatory
TIDMARCH
RNS Number : 7878J
ARC Capital Holdings Limited
05 July 2011
ARC Capital Holdings Limited
5 July 2011
ARC Capital Holdings Limited
ARCH Investment in Buchang Pharmaceutical Group
ARC Capital Holdings Limited ("ARCH" or the "Company") (AIM:
ARCH) is pleased to announce that it has invested US$13 million in
cash for a minority interest in Buchang Pharmaceutical Group
("Buchang").
Founded in 1993, and headquartered in Shandong Province, Buchang
is a leading non-SOE (state owned enterprise) pharmaceutical
company in China and the largest Traditional Chinese Medicine (TCM)
company by net profit in 2009. Buchang is mainly engaged in the
R&D, production and sales of TCM in cardiovascular disease,
holding the largest number of TCM patents, a large product
portfolio, leading market share, the largest number of sales staff
and a formidable sales network amongst all the pharmaceutical
companies in China.
TCM is one of the fastest growing industries in China,
accounting for approximately 25% of China's pharmaceutical industry
with CAGR of approximately 20%. ARCH believes that China's
pharmaceutical market is poised for significant growth given the
low expenditure as a percentage of GDP compared to other countries,
China's largely ageing population and rising disposable income,
favourable government policies and broadening insurance coverage
promoted by regulators, and a rapidly growing number of hospitals
and pharmacies supported by government spending.
For more information, please contact:
MANAGER: LEGAL COUNSEL:
Allan Liu, Managing Partner Jon Lewis, General Counsel
c/o ARC Capital Partners PAG
Limited 15/F, AIA Central
32/F, AIA Central 1 Connaught Road
1 Connaught Road Central, Hong Kong
Central, Hong Kong T: (852) 2918 0088
T: (852) 2918 0088 F: (852) 2918 0881
F: (852) 2918 0881 jlewis@pacific-alliance.com
aliu@pacific-alliance.com
----------------------------- -----------------------------
BROKER: NOMINATED ADVISER:
Hiroshi Funaki Philip Secrett
LCF Edmond de Rothschild Grant Thornton Corporate
Securities Finance
T: (44) 20 7845 5960 T: (44) 20 7383 5100
F: (44) 20 7845 5961 Philip.J.Secrett@uk.gt.com
funds@lcfr.co.uk
Numis Securities Limited
David Benda / Hugh Jonathan
T: (44) 20 7260 1000
F: (44) 20 7260 1001
d.benda@numiscorp.com
----------------------------- -----------------------------
INVESTOR RELATIONS: MEDIA RELATIONS:
Chong Min Yi Stephanie Barry
PAG PAG
T: (852) 3719 3319 T: (852) 3719 3375
cyi@pacific-alliance.com sbarry@pacific-alliance.com
----------------------------- -----------------------------
About ARC Capital Holdings Limited
ARC Capital Holdings Limited ("ARCH") (AIM: ARCH) is a
closed-end investment company with net assets of US$552.5 million
as at 31 May 2011. ARCH was admitted to trading on the AIM Market
of the London Stock Exchange in June 2006. ARCH makes and holds
investments in the retail, consumer goods and consumer services
sectors, principally in China but also in neighbouring Asian
countries. Target investments include regional hypermarkets and
supermarkets, dominant consumer brands, specialty retail chains,
retail property assets and retail and consumer service
providers.
For more information about ARC Capital Holdings Limited, please
visit: www.arch-fund.com
ARC Capital Holdings Limited is a member of PAG (formerly known
as Pacific Alliance Group), the Asian alternative investment fund
management group. Founded in 2002, PAG is now one of the region's
largest Asia-focussed alternative investment managers, with funds
under management across Private Equity, Real Estate and Hedge Funds
and Special Situations.
PAG has over 260 staff across offices in Hong Kong, Tokyo,
Beijing, Hangzhou, Shanghai, and Tianjin, as well as a presence in
Delhi and Seoul.
For more information about PAG, please visit:
www.pacific-alliance.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCUGUMUMUPGGUA
Grafico Azioni Arc Capital (LSE:ARCH)
Storico
Da Set 2024 a Ott 2024
Grafico Azioni Arc Capital (LSE:ARCH)
Storico
Da Ott 2023 a Ott 2024